Clin2
NCT06995885Possibly a fitEnrolling by invitation

A study to improve tracking of opioid use in the fentanyl era

Substance Use Disorders (SUDs)

Part of Mental health clinical trials.

This study aims to develop a better tool for recalling and tracking opioid use patterns, especially with fentanyl. It may help people who use opioids outside of medical settings to more accurately report their use.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 99 years
Study type
Observational

Who can take part

  • You are 18 years old or older.
  • You use opioids (such as heroin or fentanyl) obtained outside of a pharmacy or medical setting at least once a week.
  • You can read and understand English.
  • You are willing to provide written consent to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07094672Not yet recruiting
Opioid withdrawal symptom study

This study aims to better understand how people experience opioid withdrawal. You will be asked to describe your symptoms, which may help develop a new tool to measure withdrawal more accurately.

Baltimore, Maryland
NCT06643988Recruiting
Memory and thinking study for opioid use disorder

This study looks at how people with opioid use disorder remember personal events. You'll do tasks on a cellphone and at home while taking medication for opioid use disorder.

Philadelphia, Pennsylvania
NCT06379984Recruiting· Phase 2
Quick-start buprenorphine for opioid addiction with fentanyl use

This trial tests a way to quickly start buprenorphine (a medication for opioid addiction) in an outpatient clinic for people who use fentanyl. It aims to make starting treatment easier and faster, without needing to go through full withdrawal first.

Philadelphia, Pennsylvania
NCT05033028Recruiting· Phase 3
Using a smartphone to support opioid addiction recovery

This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.

Piscataway, New Jersey
NCT06341608Not yet recruiting
Telehealth for opioid use disorder treatment

This study tests whether a tailored telehealth program can help people with opioid use disorder get better access to treatment. It is designed for patients who are already receiving or starting treatment with buprenorphine at Prevention Point Philadelphia.

Philadelphia, Pennsylvania
NCT06877858Recruiting· Phase 1
MethaLoad dose-finding study for opioid use disorder

This study tests a new way to start methadone treatment (called 'MethaLoad') for people with opioid use disorder who have used fentanyl. If you qualify, you will receive methadone to help manage withdrawal and reduce cravings, and the doctors will closely monitor your safety and response.

Philadelphia, Pennsylvania

Hear when a new Substance Use Disorders (SUDs) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.